Our proprietary platform selectively deliver drugs to damaged elastin. We already have proof of concept in cardiovascular calcification, aneurysms and emphysema animal models.Elastrin Therapeutics Inc. is a biotech startup set to rejuvenate cardiovascular diseases. Our mission is to develop innovative therapies that target the root causes of cardiovascular conditions, providing new hope for patients and their families. We are dedicated to advancing the field of biotechnology through cutting-edge research and collaborative partnerships.
